VTCN1
Basic information
Region (hg38): 1:117143587-117210960
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the VTCN1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 0 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 0 | 0 | 0 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
VTCN1 | protein_coding | protein_coding | ENST00000369458 | 5 | 67348 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.37e-12 | 0.00722 | 125653 | 0 | 95 | 125748 | 0.000378 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.861 | 125 | 155 | 0.805 | 0.00000791 | 1841 |
Missense in Polyphen | 37 | 54.435 | 0.67971 | 626 | ||
Synonymous | 0.180 | 60 | 61.8 | 0.971 | 0.00000330 | 566 |
Loss of Function | -0.996 | 16 | 12.2 | 1.31 | 6.03e-7 | 142 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00129 | 0.00129 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000874 | 0.000870 |
Finnish | 0.0000464 | 0.0000462 |
European (Non-Finnish) | 0.000134 | 0.000123 |
Middle Eastern | 0.000874 | 0.000870 |
South Asian | 0.000751 | 0.000752 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Negatively regulates T-cell-mediated immune response by inhibiting T-cell activation, proliferation, cytokine production and development of cytotoxicity. When expressed on the cell surface of tumor macrophages, plays an important role, together with regulatory T-cells (Treg), in the suppression of tumor- associated antigen-specific T-cell immunity. Involved in promoting epithelial cell transformation. {ECO:0000250|UniProtKB:Q7TSP5, ECO:0000269|PubMed:15878339, ECO:0000269|PubMed:16606666, ECO:0000269|PubMed:17509674, ECO:0000269|PubMed:17875732}.;
- Pathway
- Cell adhesion molecules (CAMs) - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.0858
Intolerance Scores
- loftool
- 0.754
- rvis_EVS
- 0.24
- rvis_percentile_EVS
- 69.21
Haploinsufficiency Scores
- pHI
- 0.152
- hipred
- N
- hipred_score
- 0.170
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0365
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Vtcn1
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; immune system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype;
Gene ontology
- Biological process
- response to protozoan;adaptive immune response;positive regulation of T cell proliferation;negative regulation of T cell proliferation;negative regulation of apoptotic process;regulation of immune response;T cell receptor signaling pathway;negative regulation of T cell activation;interleukin-4 secretion;interferon-gamma secretion;positive regulation of interleukin-2 secretion
- Cellular component
- external side of plasma membrane;integral component of membrane
- Molecular function
- molecular_function;signaling receptor binding